title: [Efficacy of adalimumab].
abstract: After a comment about new biologic treatments in psoriasis, we do a revision about efficiency with adalimumab: mechanism form, therapeutic indications, different guidelines and doses, and review of principals clinical trials about adalimumab in psoriasis, particularly CHAMPION and REVEAL.
authors.affiliation: Servicio Dermatología. Hospital La Paz. Universidad Autónoma de Madrid. España. mcasado.hulp@salud.madrid.org
authors.forename: M
authors.initials: M
authors.lastname: Casado
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab